Back
Coeptis Therapeutics Holdings, Inc. 10K Form
Sell
50
COEP
Coeptis Therapeutics Holdings, Inc.
Last Price:
$11.81
Seasonality Move:
2.73%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive COEP News And Ratings
See the #1 stock for the next 7 days that we like better than COEP
COEP Financial Statistics
Sales & Book Value
| Annual Sales: | $1.4M |
|---|---|
| Cash Flow: | $-1.7M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $3.00 |
| Price / Book: | 4.52 |
Profitability
| EPS (TTM): | -2.80040 |
|---|---|
| Net Income (TTM): | $-12.3M |
| Gross Margin: | $-2.8M |
| Return on Equity: | -118.83% |
| Return on Assets: | -83.92% |
Coeptis Therapeutics Holdings, Inc. Earnings Forecast
Key Coeptis Therapeutics Holdings, Inc. Financial Ratios
-
The Gross Profit Margin over the past 8 years for COEP is -207.81%.
-
The Selling, General & Administrative Expenses for COEP have been equal to 91.93% of Gross Profit Margin.
-
The Research & Development expenses have been 93.71% of Revenue.
-
The Net Earning history of COEP is -900.75% of Total Revenues.
-
Per Share Earnings over the last 8 years have been positive in 4 years.
Coeptis Therapeutics Holdings, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | COEP |
| Website: | coeptistx.com |
Debt
| Debt-to-Equity Ratio: | 0.02 |
|---|---|
| Current Ratio: | 4.16 |
| Quick Ratio: | 3.59 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
COEP Technical Analysis vs Fundamental Analysis
Sell
50
Coeptis Therapeutics Holdings, Inc. (COEP)
is a Sell
Is Coeptis Therapeutics Holdings, Inc. a Buy or a Sell?
-
Coeptis Therapeutics Holdings, Inc. stock is rated a SellThe current Coeptis Therapeutics Holdings, Inc. [COEP] share price is $11.98. The Score for COEP is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.